1. Home
  2. CR vs BIO Comparison

CR vs BIO Comparison

Compare CR & BIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Crane Company

CR

Crane Company

HOLD

Current Price

$208.41

Market Cap

11.9B

Sector

Industrials

ML Signal

HOLD

Logo Bio-Rad Laboratories Inc.

BIO

Bio-Rad Laboratories Inc.

HOLD

Current Price

$380.03

Market Cap

8.0B

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
CR
BIO
Founded
1855
1952
Country
United States
United States
Employees
7100
N/A
Industry
Metal Fabrications
Biotechnology: Laboratory Analytical Instruments
Sector
Industrials
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
11.9B
8.0B
IPO Year
2022
1994

Fundamental Metrics

Financial Performance
Metric
CR
BIO
Price
$208.41
$380.03
Analyst Decision
Strong Buy
Buy
Analyst Count
5
4
Target Price
$226.20
$339.75
AVG Volume (30 Days)
449.2K
278.6K
Earning Date
04-27-2026
04-30-2026
Dividend Yield
0.58%
N/A
EPS Growth
23.96
142.61
EPS
2.78
N/A
Revenue
$2,305,000,000.00
$2,583,200,000.00
Revenue This Year
$27.98
$2.74
Revenue Next Year
$5.76
$3.20
P/E Ratio
$74.28
N/A
Revenue Growth
8.16
0.65
52 Week Low
$159.58
$236.73
52 Week High
$230.50
$380.71

Technical Indicators

Market Signals
Indicator
CR
BIO
Relative Strength Index (RSI) 40.31 78.33
Support Level $205.13 $289.16
Resistance Level $227.23 N/A
Average True Range (ATR) 6.12 12.16
MACD -1.85 1.66
Stochastic Oscillator 11.93 93.14

Price Performance

Historical Comparison
CR
BIO

About CR Crane Company

Crane is a diversified industrial firm that manufactures a broad range of products, including valves, pumps, aerospace components, and fiberglass-reinforced plastic panels. Its business is organized into two segments: aerospace and advanced technologies, and process flow technologies. Crane generated approximately $2.3 billion in revenue in 2025.

About BIO Bio-Rad Laboratories Inc.

Bio-Rad Laboratories, headquartered in Hercules, California, develops, manufactures, and sells products and solutions for the clinical diagnostics and life sciences markets. In clinical diagnostics (60% of sales), Bio-Rad sells test systems and specialized quality controls for clinical laboratories. In life sciences (40% of sales), it develops and manufactures instruments and reagents used in research, biopharmaceutical production, and food testing and has a leadership position in dPCR technology. The company is geographically diverse, with major markets in the Americas (about 40% of sales), Europe (about 30%), Asia (about 30%), and other. Bio-Rad owns approximately 33% of Sartorius, a lab and bioprocessing supplier that specializes in single-use technology used in biologics manufacturing.

Share on Social Networks: